Craig Lipkin

Princeton Satellite Systems (United States) — United States

Medicine · Health Sciences

11h-index594citations54works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antiplatelet Therapy and Cardiovascular Diseases(10), Acute Myeloid Leukemia Research(9), Neutropenia and Cancer Infections(8), Substance Abuse Treatment and Outcomes(6), Atrial Fibrillation Management and Outcomes(6)

Publications54 total

Corrigendum to “Outpatient revisits associated with three sentinel lymph node detection techniques for breast cancer: A propensity score weighted analysis” [Clin. Surg. Oncol. 4 (2025)100087]
Clinical Surgical Oncology·2025Open Access
Outpatient revisits associated with three sentinel lymph node detection techniques for breast cancer: A propensity score weighted analysis
Clinical Surgical Oncology·2025· 1 citedOpen Access
1373-P: Comparison of Characteristics among Individuals with Established vs. Newly Diagnosed Type 2 Diabetes during Ischemic Stroke Hospitalization—A Retrospective Cohort Study
Diabetes·2025
Associations between procedural volume, costs, and outcomes of septal reduction therapies for obstructive hypertrophic cardiomyopathy in US hospitals
Journal of Medical Economics·2025· 2 citedOpen Access
CO12 Predictors of Treatment and Recovery Among Obese Patients in the United States: A Retrospective Observational Study Using the PINC AI Healthcare Database (PHD)
Value in Health·2024Open Access
EE381 Comparative Analysis of Patient Outcomes and Hospital Costs: Robotic-Assisted Surgery Versus Conventional Laparoscopic Surgery Across Five Procedures
Value in Health·2024Open Access
CO178 Access to Preventive Care and Social Determinants of Child Obesity: A Retrospective Cohort Study Using the Pinc AI™ Healthcare Database (PHD)
Value in Health·2024Open Access
Real-World Evidence on the Impact of Incident AKI on Mortality, Healthcare Resource Utilization, and Costs Among Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass (CPB) from US Hospitals
Journal of the American Society of Nephrology·2023
Association between hospital volume, clinical events, resource utilization, and costs of septal myectomy and alcohol septal ablation procedures in US patients with hypertrophic cardiomyopathy
European Heart Journal·2023· 1 citedOpen Access
Trends in Maternal Mortality and Severe Maternal Morbidity During Delivery-Related Hospitalizations in the United States, 2008 to 2021
JAMA Network Open·2023· 156 citedOpen Access
Ninety-day all-cause emergency room use among coronary artery bypass grafting patients associated with near-infrared fluorescence imaging: a retrospective cohort study
Annals of Medicine and Surgery·2023· 1 citedOpen Access
Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induction chemotherapy
Future Oncology·2022· 6 citedOpen Access
Healthcare Resource Utilization for Oral Anticoagulant Reversal Therapies in Non-Valvular Atrial Fibrillation/Venous Thromboembolism Patients
Cardiology Research·2022· 2 citedOpen Access
Comparison of Hospital Length of Stay and Supportive Care Utilization Between Patients Treated with CPX-351 and 7+3 for Therapy-Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia-Related Changes
SHILAP Revista de lepidopterología·2022· 4 citedOpen Access
Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds
Clinical and Applied Thrombosis/Hemostasis·2022· 12 citedOpen Access
Healthcare Resource Utilization and Costs in US Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Chemotherapy
Blood·2021
Is Coronavirus Disease 2019 (COVID-19) Less Deadly Now? Trends in In-Hospital Mortality Among Hospitalized COVID-19 Patients in the United States
Clinical Infectious Diseases·2021· 17 citedOpen Access
PCN51 Annual Healthcare Resource Utilization and Costs in U.S. Patients Diagnosed with Relapsed Acute Myeloid Leukemia
Value in Health·2021
Abstract P403: Healthcare Resource Utilization and Costs Associated With Oral Anticoagulant Reversal With Idarucizumab or Andexanet Alfa for Patients Hospitalized With Life-Threatening Bleeding Events
Stroke·2021
Annual Healthcare Resource Utilization and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia
Blood·2020
page 1 of 3Next →

Frequent Co-authors

Zhun Cao(30), Scott B. Robinson(14), Frank R. Ernst(9), Jay Bae(7), Zhenxiang Zhao(7), Chad Moretz(7), Helen M. Pettinati(6), Douglas E. Faries(6), Seth L. Emont(6), Christopher C. Dvorak(6), Kathleen F. Villa(5), Bijan Nejadnik(5), David Huggar(5), Ronda Copher(5), Thomas W. LeBlanc(5), R.A. Balk(4), Sameer S. Kadri(4), Joseph R. Volpicelli(4), Alex C. Spyropoulos(4), Bríain ó Hartaigh(4)